Differing Viewpoints: Does FDA Need More Post-Market Authority?
This article was originally published in The Gray Sheet
Executive Summary
Consumer and patient advocates say FDA needs more post-market authorities from Congress for 510(k)-cleared devices, but manufacturers argue that the agency should be able to work with what it has.